TIDES USA: Oligonucleotide & Peptide Therapeutics is an annual conference dedicated to oligonucleotide and peptide, covering the entire spectrum of oligonucleotides, peptides, mRNA, and genome editing in early discovery to late-stage development and commercialization.
We are excited to announce TIDES USA will return to Boston in 2022 as a hybrid event, accommodating for both in-person and virtual attendees. We hope you will join GenScript and our presentation on peptide-based drug development as we continue to celebrate our community and the advancement of drug discovery and biotechnology innovation.
Topic: Drug Development Using Designed Cyclic Peptides
Speaker Bio:
Patrick Finneran is Senior Scientist at Menten AI. He received his PhD from Brandeis University where his research was focused on the evolution of Non-Receptor Tyrosine Kinases and their regulation and specificity in regard to a wide variety of natural and synthetic peptides. At Menten AI, Patrick helps lead the team responsible for characterizing the computationally designed cyclic peptides using biochemical, biophysical, and pharmacological assays.
